Health Technology Assessment

67 Items

All Items

  • Cost of illness of cutaneous squamous cell carcinoma (CSCC)

    Andrea Marcellusi, Chiara Bini, Ketty Peris, Paolo Antonio Ascierto, Francesco Saverio Mennini
    148-153
    DOI: https://doi.org/10.33393/grhta.2020.2171

  • Cost-effectiveness of adding psychomotor therapy to a multidisciplinary rehabilitation program for chronic pain

    Lia van der Maas, Judith E. Bosmans, Maurits W. van Tulder, Thomas W.J. Janssen
    124-130
    DOI: https://doi.org/10.33393/grhta.2020.2031

  • Cost-effectiveness and budget impact of a lifestyle intervention to improve cardiometabolic health in patients with severe mental illness

    Anne Looijmans, Frederike Jörg, Richard Bruggeman, Robert A. Schoevers, Eva Corpeleijn, Talitha L Feenstra, Antoinette D.I. van Asselt
    131-138
    DOI: https://doi.org/10.33393/grhta.2020.2027

  • Towards standardization of economic evaluation research in the youth psychosocial care sector: A broad consultation in the Netherlands

    Silvia M.A.A. Evers, Carmen D. Dircksen
    117-123
    DOI: https://doi.org/10.33393/grhta.2020.2143

  • Factors influencing short-term effectiveness and efficiency of the care provided by Dutch general practice mental health professionals

    Tosca G.R. Vennemann, Ben F.M. Wijnen, Lianne Ringoir, Audry Kenter, Marja J.H. van Bon-Martens, Rob J.M. Alessie, Jasper Nuyen
    139-147
    DOI: https://doi.org/10.33393/grhta.2020.2028

  • Mental health economics: the Netherlands experience

    Aileen Murphy, Antoinette D.I. Van Asselt
    115-116
    DOI: https://doi.org/10.33393/grhta.2020.2172

  • Economic burden of prescriptive inadequacy in the management of osteoarthritis in Italy Il burden economico dell’inappropriatezza prescrittiva nella gestione dell’osteoartrite in Italia

    Michele Basile, Filippo Rumi, Marco Palmeri, Ivano Mattozzi, Lamberto Manzoli, Massimo Mammuccari, Sergio Gigliotti, Roberto Bernabei, Americo Cicchetti
    101-108
    DOI: https://doi.org/10.33393/grhta.2020.2130

  • Cost-utility of dalbavancin in patients with non-severe ABSSSI in Italy

    Andrea Marcellusi, Chiara Bini, Maria Assunta Rotundo, Rosario Cultrera, Francesco Saverio Mennini
    92-100
    DOI: https://doi.org/10.33393/grhta.2020.2138

  • Erratum in: Budget Impact Analysis of anakinra in the treatment of patients with Still’s Disease

    Roberto Ravasio, Roberto Giacomelli, Stefano Bianchi
    91
    DOI: https://doi.org/10.33393/grhta.2020.2187

  • Budget Impact Analysis of anakinra in the treatment of patients with Still’s Disease Analisi di budget impact di anakinra nel trattamento della Malattia di Still in Italia

    Roberto Ravasio, Roberto Giacomelli, Stefano Bianchi
    72-80
    DOI: https://doi.org/10.33393/grhta.2020.2140

  • Patterns of prescription, hospitalizations and costs of herpes zoster in patients at risk, from a large Italian claims database

    Silvia Calabria, Giulia Ronconi, Letizia Dondi, Carlo Piccinni, Antonella Pedrini, Immacolata Esposito, Pierluigi Viale, Nello Martini
    66-71
    DOI: https://doi.org/10.33393/grhta.2020.2026

  • Cost-effectiveness analysis of dupilumab for the treatment of severe atopic dermatitis in adults in Italy Analisi costo-utilità di dupilumab per il trattamento della dermatite atopica grave negli adulti in Italia

    Antonio Costanzo, Gianluca Furneri, Rossella Bitonti, Maria Paola Pedone, Francesca Fanelli, Roberta Di Turi
    57-65
    DOI: https://doi.org/10.33393/grhta.2020.710

  • Multidisciplinary approach to psoriasis in the Spanish National Health System: A social return on investment study

    Gregorio Carretero, David Moreno, Almudena González Domínguez, David Trigos, Albert Ledesma, Esther Sarquella, María Merino, Carles Blanch, SROI Psoriasis Group
    50-56
    DOI: https://doi.org/10.33393/grhta.2020.2146

  • Budget impact analysis of extended half-life recombinant factor IX (rFIXFc) in the treatment of haemophilia B

    Andrea Aiello, Maria Elisa Mancuso, Alessio Colombo, Cristina Teruzzi, Patrizia Berto
    40-49
    DOI: https://doi.org/10.33393/grhta.2020.2113

  • The effects of disease cross-coverage by dupilumab on the costs sustained by the Italian National Health Service

    Claudio Jommi, Filippo Cipriani, Francesca Fanelli, Maria Paola Pedone, Walter Canonica
    33-39
    DOI: https://doi.org/10.33393/grhta.2020.2139

  • Evaluation of the use of Floseal®, a topical hemostatic agent, in cardiothoracic surgery

    Rossella Di Bidino, Luz Irene Urbina, Marco Oradei, Amerigo Cicchetti
    14-25
    DOI: https://doi.org/10.33393/grhta.2020.695

  • A cost-minimization analysis of a preventive testing strategy for relatives of patients with BRCA mutated ovarian cancer

    Eugenio Di Brino, Matteo Ruggeri, Stefania Boccia, Nicoletta Cerana, Domenica Lorusso, Dario Sacchini, Antonella Savarese, Liliana Varesco, Americo Cicchetti
    1-8
    DOI: https://doi.org/10.33393/grhta.2020.557
51-75 of 67